Canada · Series B startup
Funding summaryUpdated 26 Oct 2026
$93Mraised across 3 rounds since 2014, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
New Enterprise Associates
OrbiMed
RA Capital Management
Rock Springs Capital
EcoR1 CapitalFrom a historical funding recordSEC filing: $60M sold, first sale Jun 2015
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
OrbiMed
BDC CapitalNew Enterprise AssociatesRA Capital ManagementRock Springs CapitalEcoR1 CapitalJanus Capital GroupUCB PharmaMissing a round, or an investor who was in one? Tell us.
Clementia Pharmaceuticals's investors include OrbiMed, BDC Capital, New Enterprise Associates, RA Capital Management and Rock Springs Capital, and 3 more on record.
Clementia Pharmaceuticals has raised $93M across 3 rounds since 2014.
Clementia Pharmaceuticals's most recent round was a Series B of $60M in Jun 2015.
Its most recent round, $60M in Jun 2015, is also its largest on record.
Clementia Pharmaceuticals's first round on record, in Jan 2014, was backed by BDC Capital and OrbiMed.
Clementia Pharmaceuticals's latest named round is a Series B, in Jun 2015.
Clementia Pharmaceuticals is based in Canada.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Canada · 
